Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Subscribers Only
Access The Future of Epidemic Prevention Lies in Wastewater Analysis For Free!
-

The Future of Epidemic Prevention Lies in Wastewater Analysis

September 17, 2024
Published
-
September 17, 2024
Subscribers Only
Access Ginkgo Bioworks Teams with Quest Diagnostics to Provide COVID-19 Testing for K-12 Schools Nationwide For Free!
digest
-

Ginkgo Bioworks Teams with Quest Diagnostics to Provide COVID-19 Testing for K-12 Schools Nationwide

May 4, 2021
Published
-
May 4, 2021
Subscribers Only
Access Nēsos receives FDA Breakthrough Device Designation for its disease modifying digital therapeutic for Rheumatoid Arthritis For Free!
digest
-

Nēsos receives FDA Breakthrough Device Designation for its disease modifying digital therapeutic for Rheumatoid Arthritis

April 23, 2021
Published
-
April 23, 2021
Subscribers Only
Access Oxitec Receives US$6.8 Million from Wellcome Trust to Advance Scale-up of Friendly™ Aedes aegypti Technology For Free!
digest
-

Oxitec Receives US$6.8 Million from Wellcome Trust to Advance Scale-up of Friendly™ Aedes aegypti Technology

April 22, 2021
Published
-
April 22, 2021
Subscribers Only
Access Pure Biologics Selects Twist Bioscience to Expand Phage Display Technology Capabilities For Free!
digest
-

Pure Biologics Selects Twist Bioscience to Expand Phage Display Technology Capabilities

April 15, 2021
Published
-
April 15, 2021
Subscribers Only
Access Senti Bio Enters Collaboration with Spark Therapeutics to Develop Next-Generation Precision Gene Therapies For Free!
digest
-

Senti Bio Enters Collaboration with Spark Therapeutics to Develop Next-Generation Precision Gene Therapies

April 13, 2021
Published
-
April 13, 2021
Subscribers Only
Access Scribe Therapeutics Raises $100M Series B Financing to Further Develop “CRISPR by Design” Platform and Pipeline of Breakthrough Genetic Medicines For Free!
digest
-

Scribe Therapeutics Raises $100M Series B Financing to Further Develop “CRISPR by Design” Platform and Pipeline of Breakthrough Genetic Medicines

April 13, 2021
Published
-
April 13, 2021
Subscribers Only
Access Helix Announces Partnership with Ginkgo Bioworks to Support Back to School COVID-19 Testing Across the Western U.S. For Free!
digest
-

Helix Announces Partnership with Ginkgo Bioworks to Support Back to School COVID-19 Testing Across the Western U.S.

April 13, 2021
Published
-
April 13, 2021
Subscribers Only
Access Twist Bioscience to Provide Antibody Discovery, Optimization and Access to Library of Libraries for Drug Research to Stanford University Laboratories For Free!
digest
-

Twist Bioscience to Provide Antibody Discovery, Optimization and Access to Library of Libraries for Drug Research to Stanford University Laboratories

April 8, 2021
Published
-
April 8, 2021
Subscribers Only
Access Olive Labs Inc. Announces Partnership with Ginkgo Bioworks to Scale COVID Response through Pooled Testing in K-12 Schools For Free!
digest
-

Olive Labs Inc. Announces Partnership with Ginkgo Bioworks to Scale COVID Response through Pooled Testing in K-12 Schools

April 2, 2021
Published
-
April 2, 2021
Subscribers Only
Access Breaking News: New Kingdom of Life Discovered For Free!
fiona.mischel
-

Breaking News: New Kingdom of Life Discovered

April 1, 2021
Published
-
April 1, 2021
Subscribers Only
Access Dascena Labs Announces Partnership with Concentric by Ginkgo to Scale COVID Response through K-12 Classroom Testing For Free!
digest
-

Dascena Labs Announces Partnership with Concentric by Ginkgo to Scale COVID Response through K-12 Classroom Testing

March 31, 2021
Published
-
March 31, 2021
Subscribers Only
Access Twist Bioscience and Biotia Receive U.S. FDA Emergency Use Authorization for First Hybridization Capture-Based Next-Generation Sequencing SARS-CoV-2 Assay For Free!
digest
-

Twist Bioscience and Biotia Receive U.S. FDA Emergency Use Authorization for First Hybridization Capture-Based Next-Generation Sequencing SARS-CoV-2 Assay

March 25, 2021
Published
-
March 25, 2021
Subscribers Only
Access Provectus Algae Appoints CEO of Senti Biosciences to Board to Aid Advancement of High-Throughput Synthetic Biology Platform For Free!
digest
-

Provectus Algae Appoints CEO of Senti Biosciences to Board to Aid Advancement of High-Throughput Synthetic Biology Platform

March 25, 2021
Published
-
March 25, 2021
Subscribers Only
Access Can Monoclonal Antibodies Cure Alzheimer’s? For Free!
Robin Seaton Jefferson
-

Can Monoclonal Antibodies Cure Alzheimer’s?

March 23, 2021
Published
-
March 23, 2021
Subscribers Only
Access AbSci Announces Completion of $125 Million Crossover Financing to Advance AI-Powered Synthetic Biology Drug Creation Platform For Free!
digest
-

AbSci Announces Completion of $125 Million Crossover Financing to Advance AI-Powered Synthetic Biology Drug Creation Platform

March 23, 2021
Published
-
March 23, 2021
Subscribers Only
Access M2GEN Announces New Collaboration with Merck to Advance Cancer Therapies For Free!
digest
-

M2GEN Announces New Collaboration with Merck to Advance Cancer Therapies

March 19, 2021
Published
-
March 19, 2021
Subscribers Only
Access CD&R, Merck GHI, and McKesson Ventures Invest in Innovative Oncology Data and Informatics Company M2GEN For Free!
digest
-

CD&R, Merck GHI, and McKesson Ventures Invest in Innovative Oncology Data and Informatics Company M2GEN

March 19, 2021
Published
-
March 19, 2021
Subscribers Only
Access Twist Bioscience Begins Shipping of Synthetic RNA Controls for B.1.351 and P.1 Variants For Free!
digest
-

Twist Bioscience Begins Shipping of Synthetic RNA Controls for B.1.351 and P.1 Variants

March 16, 2021
Published
-
March 16, 2021
Subscribers Only
Access insitro Raises $400 Million in Series C Financing For Free!
digest
-

insitro Raises $400 Million in Series C Financing

March 15, 2021
Published
-
March 15, 2021
Subscribers Only
Access Octarine Bio announces closing of extended seed round financing of $1.2 million USD with an uptick in valuation due to significant investor demand. For Free!
digest
-

Octarine Bio announces closing of extended seed round financing of $1.2 million USD with an uptick in valuation due to significant investor demand.

March 13, 2021
Published
-
March 13, 2021